Hytrast, a new bronchographic medium of high iodine content, provides excellent radiographic contrast. A number of clinical, pathological, and experimental studies have revealed inflammatory changes after pulmonary retention of Hytrast. Examination of 43 unselected pneumonectomy specimens after Hytrast bronchography revealed typical crystals in 15 instances. The pulmonary reaction included macrophage and foreign body giant cell accumulation, neutrophil leucocyte exudation, and fibrosis within terminal bronchioles and alveoli. It was concluded that these changes were associated with Hytrast retention.
The gradual refinement of bronchographic contrast media has been reviewed by Le Roux and Duncan (1964) . Iodized poppy seed oil (Lipiodol) has been used since 1922 (Sicard and Forestier, 1922) . The addition of sulphanilamide (Visciodol) increased viscosity and reduced alveolar filling, but the occasional complications of methaemoglobinaemia, allergic sensitization, and acute nephritis stimulated the search for a better preparation. In 1953 propyliodone in aqueous solution (Dionosil aqueous) became available but was found to be a mucosal irritant, an objection which suspension in an oily medium (Dionosil oily) overcame.
Hytrast, introduced as a bronchographic medium in 1962, is a neutral suspension of crystals of N (propyl-2: 3-diol)-3: 5 diiodo-4-pyridone, and 3: 5 diiodo-4 pyridone in a hypertonic aqueous solution of sodium carboxymethylcellulose. The latter compound was introduced to maintain the viscosity at 24-2-8 poise and the pH at 7-1. The crystals are 2-5 microns across (Le Roux and Duncan, 1964) . Esteric groups are not present and hydrolysis to irritant acidic groups does not occur. The concentration of iodine is higher than in previous contrast media (05 g./ml. in Hytrast, 0-28 g. /ml. in Dionosil). Gildenhorn, Springer, Wang, and Hallett (1962), Le Roux and Duncan (1964) , and Webb and Fitts (1963) commented on the high quality of bronchograms obtained with Hytrast and on the low incidence of alveolar filling. None of these authors observed a pulmonary reaction to Hytrast, but it has since become apparent that pathological changes may follow its use. Thirty-eight cases have been reported and a single fatality (Agee and Shires, 1965) . The number of lung specimens examined by any one author is small, excluding Nelson, Christoforidis, and Pratt (1964) , who examined 14 specimens, and the cases described were self-selected by clinical or pathological abnormalities attributable to Hytrast. Because these are a selected group, the severity of the pulmonary reaction to Hytrast may not be representative of the 'bronchogram' population as a whole. An unselected series of lobectomy and pneumonectomy specimens in which Hytrast bronchography had previously been performed was therefore examined.
RESULTS
Forty-three unselected pneumonectomy specimens, excised between July 1966 and March 1967, were available for study.
The differences of the mean times between bronchography and resection are not significant: P=0-20-0-10. Table I shows that there was no significant difference in the mean times elapsing between bronchography and excision in the group containing Hytrast when compared with the group in debris, which appeared to be the remains of degenerate macrophages (Fig. 2) .
In eight specimens Hytrast was present in the bronchial passages (Fig. 4) In seven cases Hytrast was associated with neutrophils ( Fig. 2) , and in four the focus of Hytrast was related to carcinoma, bronchiectasis, or a mycetoma. It seems unreasonable in these cases to ascribe the inflammatory cell infiltrate to the bronchographic medium. However, in three specimens with carcinoma of the lung, alveolar tissue adjacent to the Hytrast focus was normal or showed centrilobular emphysema, yet Hytrast was closely associated with neutrophil leucocytes. It therefore seems that Hytrast may cause an acute inflammatory cel response.
The difficulties of attributing a neutrophil leucocyte response to Hytrast accumulations also apply to the fibrosis which is sometimes associated. Rayl and Spjut (1963) and Nelson et al. (1964) reported similar findings. The present study shows that pulmonary tissue changes may occur without the development of a clinically apparent reaction. The finding of Hytrast retention in 15 out of 43 cases submitted to Hytrast bronchography is probably an underestimate as the study was retrospective and normal areas were not routinely sampled. Nelson et al. (1964) observed changes attributable to Hytrast in 11 out of 14 cases one to five days after bronchography. Light and Oster (1964) found Hytrast in four of 15 surgical specimens. In contrast, Webb and Fitts (1963) found no changes in 23 specimens, and Le Roux and Duncan (1964) found no changes attributable to Hytrast in four specimens.
In addition to radio-opaque crystals, Hytrast also contains carboxymethyl cellulose. De Bruin (1965) noted the presence of intra-alveolar basophilic material which was thought to be carboxymethyl cellulose, and which stained metachromatically with toluidine blue. Leopold and Seal (1961) considered the possibility that carboxymethyl cellulose may have been responsible for the tissue reaction following Dionosil bronchography. They demonstrated material which stained negatively with Schiff's reagent and positively with Alcian blue, but which was not metachromatic with tartaric acid-thionine. Whether this material was carboxymethyl cellulose is doubtful since the latter is water soluble and would probably have been removed by processing in aqueous reagents. 
